Min Qiu, Chunyan Xue, Lingyan Zhang
Department of Obstetrics and Gynecology, Changzhou First People’s Hospital, the Third Affiliated Hospital of Soochow University, Changzhou, Jiangsu, China, 213003; Department of Obstetrics and Gynecology, Hangzhou Xiasha Hospital, Hangzhou, Zhejiang, China, 310018.
Retraction note to: JBUON 2019;24(6):2316-2321; PMID: 31983100
Following the publication of this article [1], readers drew to our attention that part of the data was unreliable: Figures of this article appeared in other articles (by totally different authors). The authors were requested to provide the raw data and were also asked for an explanation to account for these concerns, however, the Editorial Office hasn’t received any reasonable reply. Now we completed the investigation and decided to retract this article. Authors were informed of the retraction. We thank the readers for bringing this matter to our attention. We apologize for any inconvenience it may cause.
References
1. Qiu M, Xue C, Zhang L. Piperine alkaloid induces anticancer and apoptotic effects in cisplatin resistant ovarian carcinoma by inducing G2/M phase cell cycle arrest, caspase activation and inhibition of cell migration and PI3K/Akt/GSK3β signalling pathway. JBUON 2019;24:2316-21.
The original article can be found online at: https://jbuon.com/archive/24-6-2316.pdf
Full Text: PDF